Anteris Technologies enrolls First US patients in global PARADIGM trial for DurAVR heart valve
Proactive - Interviews for investors · Proactive Investors
May 6, 20267m 30s
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.